ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselCabaletta Bio GmbH
Cabaletta Bio GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Cabaletta Bio GmbH is a clinical‑stage biotechnology company developing engineered T cell therapies for autoimmune diseases. It applies the Cabaletta Approach to B cell Ablation (CABA®) platform and is advancing rese‑cel, a fully human CD19‑CAR T candidate, in RESET™ Phase 1/2 trials to evaluate transient B‑cell depletion as a means to reset the immune system in conditions such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis and pemphigus vulgaris.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Cabaletta Bio GmbH

Industry:Pharmaceutical company
✓ Offered3
Development of T-cell therapies for autoimmune diseases
Development of engineered T cell therapies and Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) for the treatment of autoimmune diseases with B-cell involvement.
Rese-cel
Investigational fully human CD19 CAR T cell therapy with a 4-1BB co-stimulation domain, as a single-dose infusion for systemic lupus, myositis, systemic sclerosis, gMG and pemphigus vulgaris in clinical development.
Clinical Phase 1/2 trials within the RESET programme
Phase 1/2 clinical trials in lupus, myositis, systemic sclerosis, generalized myasthenia gravis and pemphigus vulgaris, including RESET-SLE, RESET-Myositis, RESET-SSc, RESET-MG and RESET-PV.
Trust & reputation

ranQ Trust Score of Cabaletta Bio GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Cabaletta Bio GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Cabaletta Bio GmbH scores 63.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Cabaletta Bio GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Cabaletta Bio GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Cabaletta Bio GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Cabaletta Bio GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Cabaletta Bio GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cabaletta Bio GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cabaletta Bio GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 70
4057 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-180.349.852
Founded
2024 · 2 years
Last commercial register change
October 1, 2025
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    BI
    Boehringer Ingelheim (Schweiz) GmbH
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    NP
    Novartis Pharma AG
    Basel
    BM
    BeOne Medicines I GmbH
    Basel
    HP
    Hengrui Pharmaceuticals Europe AG
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel
    RC
    Roche Chemische Unternehmungen AG
    Basel